查尔斯河实验室(Charles River,纽交所代码:CRL)今日盘中大涨5.08%,引发市场关注。公司近期公布的2024年第四季度财报数据亮眼,这是导致股价上涨的主要原因。
财报数据显示,查尔斯河第四季度每股收益为2.66美元,高于分析师一致预期的2.53美元,超出预期5.14%。季度销售额达到10.03亿美元,也高于分析师预期的9.83627亿美元,超出1.97%。这反映出公司在生物技术领域的药物开发服务需求保持稳定。
分析人士认为,借贷成本的下降可能改善了生物技术公司的融资环境,从而带动对查尔斯河等公司服务的需求。尽管如此,该公司预计中小型生物技术客户今年的需求将保持相对稳定或略有改善。查尔斯河在致力提高运营效率,以应对部分收入下降的不利影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.